On September 11, 2006, Glaxo Smith Kline (GSK) and the Internal Revenue Service (IRS) agreed to a $3.4 billion settlement, the largest in IRS history. The issue was transfer pricing. Since GSK, several transfer pricing issues arose under the 1995 Sec. 482 regulations.

Jun 7, 2005 · The IRS has filed its answer to GlaxoSmithKline Holdings' petition contesting a $1.9 billion tax deficiency based on section 482 income reallocations for asserted

Apr 12, 2005 · The Commissioner makes erroneous section 482 adjustments to cost-sharing buy-in payments by Petitioner and by Glaxo U.K. with respect to pre-existing intangible property for the taxable years ended December 31, 1997, through December 31, 2000.

Learn more about our product portfolio and how we’re prioritizing specialty medicines and vaccines to get ahead of disease together. Below you can find the full A-Z list of our products available in the United States. Unfortunately, we cannot provide comprehensive information about our products here, in compliance with regulations.

Sep 6, 2024 · GSK is heading into the weekend with a win for its respiratory blockbuster Nucala—but for now, the details are slim. On Friday, GSK said that its IL-5 antibody Nucala plus inhaled maintenance...

Apr 8, 2019 · A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in Infants

GSK offers a broad range of vaccines for your appropriate pediatric and adult patients. View Product List. US healthcare professionals can order through GSKDirect. This Printable Summary Sheet provides a summary of CPT codes for GSK vaccines. Call 1-866-GSK-VACC Monday - Friday 8 AM to 6 PM for assistance with GSK vaccines. You can also email us at

GSK-872 is a RIPK3 inhibitor, which binds RIP3 kinase domain with an IC50 of 1.8 nM, and inhibits kinase activity with an IC50 of 1.3 nM. GSK-872 decreases the RIPK3-mediated necroptosis and subsequent cytoplasmic translocation and expression of HMGB1, as well as ameliorates brain edema and neurological deficits in early brain injury.

All information about the counterparty GSK-482 (Khabarovsk Krai, TIN 2725019531) to do due diligence at the requirement of the Federal Tax Service, a check of integrity, business reputation.

GSK′481 blocks caspase inhibitor/TNF-induced necroptosis in human monocytic U937 cultures (IC 50 = 10 nM) and inhibits S166 autophosphorylation of exogenously expressed human, but not mouse, RIP1 in HEK293T transfectants (IC 50 = 2.8 nM and >10 μM, respectively). Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number.